Safety Evaluation of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 3 Months

Invest Ophthalmol Vis Sci, 41 (4):S142 (2000).

Published Date
<p>Invest Ophthalmol Vis Sci, 41 (4):S142 (2000).</p>
O’Neill, C. A, Christian B. J., Murphy, C. J., Miller, P., Verhoeve, J., Leedle, R., Dubeilzig, R. R., Beyer, J. C., Albert, D. M., and Davis, M
Approved Therapy
Investigation Type
Development Phase
Therapy Class